Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.30M | 85.10M | 86.70M | 87.60M | 79.13M | 65.48M | Gross Profit |
15.80M | 37.70M | 81.60M | 79.10M | 37.63M | 30.25M | EBIT |
-11.50M | 23.50M | 55.50M | 54.10M | 9.26M | 625.00K | EBITDA |
29.10M | -12.50M | 58.30M | 57.70M | 40.50M | 26.58M | Net Income Common Stockholders |
-10.10M | -20.10M | 11.40M | 10.90M | 3.80M | -2.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
62.20M | 55.70M | 46.70M | 118.20M | 57.29M | 91.60M | Total Assets |
1.14B | 601.60M | 1.26B | 1.38B | 1.15B | 908.20M | Total Debt |
0.00 | 516.90M | 1.16B | 1.22B | 1.05B | 851.90M | Net Debt |
-62.20M | 463.70M | 1.12B | 1.10B | 987.88M | 760.30M | Total Liabilities |
1.04B | 542.30M | 1.19B | 1.27B | 1.10B | 898.20M | Stockholders Equity |
4.40M | 59.30M | 76.50M | 103.30M | 48.25M | 10.00M |
Cash Flow | Free Cash Flow | ||||
-160.70M | 25.40M | -25.40M | 36.30M | -218.53M | -404.66M | Operating Cash Flow |
-159.60M | 28.60M | -18.90M | 39.70M | -216.12M | -401.11M | Investing Cash Flow |
-11.20M | -16.90M | 11.70M | -191.00M | -2.43M | -3.47M | Financing Cash Flow |
154.40M | -2.70M | -64.30M | 207.30M | 189.10M | 456.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £1.70B | 8.69 | 14.68% | 4.63% | 27.88% | 28.92% | |
77 Outperform | £1.81B | 6.37 | 13.70% | 6.80% | 18.67% | 17.42% | |
74 Outperform | £467.13M | 7.40 | 8.03% | 5.90% | 0.37% | ― | |
67 Neutral | £467.13M | 29.21 | 22.10% | 3.50% | 11.27% | 16.57% | |
65 Neutral | £218.18M | ― | -127.10% | ― | -20.62% | -44.96% | |
64 Neutral | $12.77B | 9.77 | 7.59% | 16985.66% | 12.30% | -7.71% | |
54 Neutral | £44.20M | ― | -16.30% | ― | -10.35% | 18.10% |